Clinical Trials Search Results
- A Multi-Center Observational Study: The RECOVER Post Acute Sequelae of SARS-CoV-2 (PASC) Pediatric Cohort Study
Research efforts focus on the long-term effects of COVID-19, called Post-Acute Sequelae of SARS-CoV-2 infection (PASC). Long COVID is a form of PASC, and refers to symptoms that persist for weeks or months after the acute infection. Research teams, including the Avera Research Institute, study and share data in real time, providing the scale needed to get answers to help alleviate suffering as fast as possible.
- A Phase 2/3, Interventional safety, pharmacokinetics, and efficacy, open-label, multi-center, single-arm study to investigate orally administered PF-07321332 (Nirmatrelvir)/Ritonavir in non-hospitalized symptomatic pediatric participants with COVID-19 who are at risk of progression to severe disease
To compare the efficacy of nirmatrelvir (PF-07321332)/ritonavir to placebo for the treatment of symtomatic COVID-19 in non- hospitalized pediatric participants with COVID-19 who are at risk of progression to severe disease. Patients are randomized 1:1 and will receive placebo or the investigational product orally for 5 days. Patients will complete in-person and remote follow-up visits including assessments such as nasapharyngeal swabs, blood draws, and physical exams. Participants will be compensated for their time.
